Q-Line Biotech IPO — GMP Today, Price Band, Dates & Listing

Q-Line Biotech SME IPO (NSE: QLINE) opened on 21 May 2026 and closed on 25 May 2026 on NSE SME. Price band Rs 326-343 (issue price Rs 343), lot size 400 shares (minimum application Rs 274,400, two lots, the SME minimum application, at the upper band). Listed on 29 May 2026 at +38.37% over the issue price on day one.

Q-Line Biotech IPO details

StatusListed
Open date21 May 2026
Close date25 May 2026
Price bandRs 326-343 (issue price Rs 343)
Lot size400 shares
Minimum investmentRs 274,400 (two lots, the SME minimum application, at the upper band)
Face valueRs.10
Issue type100 % Book Building
Issue size (Rs cr)214.48 (incl Rs 61.10 Cr anchor) — caution: figure duplicated in Advit Jewels source
Issue size (NSE summary)Initial Public Offering of Fresh Issue of up to 62,53,200 Equity Shares (including Market Maker portion of 3,13,200 Equity Shares and Anchor Allocation of 17,81,200 Equity Shares)
Listing date29 May 2026 (listed)
ExchangeNSE SME
Lead managersHem Securities Limited and Share India Capital Services Private Limited
RegistrarPurva Sharegistry (India) Private Limited
NSE symbolQLINE
ProspectusRed herring prospectus (NSE archive, zip)

Face value, lot, issue type, issue size, lead managers and registrar are as filed on NSE's IPO detail page (QLINE). Page data as of 15 Sep 2026.

Opened at Rs 452 (+31.78%), high Rs 460 (+34.11%), traded ~Rs 440 (+28.28%).

Key dates

Issue opens21 May 2026
Issue closes25 May 2026
Basis of allotment26 May 2026 (expected, T+1)
Refunds / demat credit27 May 2026 (expected, T+2)
Listing29 May 2026 (listed) on NSE SME

Post-close dates follow SEBI's T+3 listing timeline counted in working days from the close; registrar and exchange notices are final.

Q-Line Biotech listing performance

Issue priceRs 343.00
Listed on2026-05-29
Listing day openRs 452.00
Listing day closeRs 474.60
Listing gain (close vs issue)+38.37%
Latest closeRs 676.60
Return since issue+97.26%

Listing-day and latest prices from NSE end-of-day data (symbol QLINE). Latest close as of 2026-09-15. Listing-day gain is measured within the listing week and is unaffected by corporate actions; return since issue is price-only, excludes dividends and is not adjusted for splits or bonuses.

What the GMP means for Q-Line Biotech

Grey Market Premium (GMP) is the unofficial premium at which an IPO's shares change hands before listing. A positive GMP signals bullish pre-listing sentiment, but it is unregulated, volatile and routinely diverges from the actual listing price in both directions — treat it as a thermometer, never a forecast. Read our full What is GMP? guide for how the grey market works.

Apply, allotment and listing

FAQs on Q-Line Biotech IPO

What is Q-Line Biotech IPO GMP today?

Q-Line Biotech has listed, so its grey market premium no longer applies. The listing performance table on this page has the actual debut price and gain.

When did the Q-Line Biotech IPO open and close?

Q-Line Biotech's subscription window opened on 21 May 2026 and closed on 25 May 2026.

What is the Q-Line Biotech IPO price band and lot size?

For Q-Line Biotech, the price band is Rs 326-343 (issue price Rs 343) and one lot is 400 shares (minimum application Rs 274,400, two lots, the SME minimum application, at the upper band).

Who is the registrar for the Q-Line Biotech IPO?

The registrar to the Q-Line Biotech IPO is Purva Sharegistry (India) Private Limited (as filed on NSE). Allotment status is checked on the registrar's website once the basis of allotment is finalised — the link is on our Q-Line Biotech allotment status page.

How did Q-Line Biotech perform on listing day?

Q-Line Biotech listed on 29 May 2026 and closed its first day at Rs 474.60, +38.37% against the issue price (NSE end-of-day data).

Ready for the next IPO?

Open a free demat account in minutes so you can apply as soon as an issue opens.

Compare brokers for IPO applications